Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-16

Clinical Trial Update: Targeting Default Mode Network Dysfunction in Persons At Risk of Alzheimer's Disease with Non-invasive Techniques [NA]

View source ↗

Summary

A completed clinical trial evaluating non-invasive methods to target default mode network dysfunction in people at risk for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli | Conditions: Alzheimer Disease | NA | Status: COMPLETED